Is angiogenic CD4+ T-cell mediated inflammation responsible for endothelial dysfunction in essential hypertension?
- 1 May 2021
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hypertension
- Vol. 39 (5), 867-868
- https://doi.org/10.1097/hjh.0000000000002749
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Circulating senescent angiogenic T cells are linked with endothelial dysfunction and systemic inflammation in hypertensionJournal of Hypertension, 2020
- Endothelial Cell Dysfunction and the Pathobiology of AtherosclerosisCirculation Research, 2016
- Chronic Inflammatory Diseases and Endothelial DysfunctionAging and disease, 2016
- Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertensionJournal of Hypertension, 2015
- Immunosenescent CD8 + T Cells and C-X-C Chemokine Receptor Type 3 Chemokines Are Increased in Human HypertensionHypertension, 2013
- Endothelial dysfunction in rheumatic autoimmune diseasesAtherosclerosis, 2012
- Oxidative stress and endothelial dysfunction in hypertensionHypertension Research, 2011
- Natural Regulatory T Cells Control Coronary Arteriolar Endothelial Dysfunction in Hypertensive MiceThe American Journal of Pathology, 2011
- Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunctionThe Journal of Experimental Medicine, 2007
- Impaired l -Arginine Transport and Endothelial Function in Hypertensive and Genetically Predisposed Normotensive SubjectsJournal of the American College of Cardiology, 2004